Tau Protein: Coming to New Alzheimer’s Diagnostics and Treatments Near You
When neurologists first studied the brains of people with Alzheimer’s, more than 100 years ago, they spotted two abnormal clumps of proteins — beta-amyloid…
When neurologists first studied the brains of people with Alzheimer’s, more than 100 years ago, they spotted two abnormal clumps of proteins — beta-amyloid…
Much of Alzheimer’s research has focused on beta-amyloid plaques, one of the main drivers behind neurodegeneration in people with dementia. But more and more…
While not every elderly person develops Alzheimer’s, age is a risk factor for the disease. Currently, one in 10 people over the age of…
Tau protein tangles (or neurofibrillary tangles) are a hallmark of Alzheimer’s disease, but what role do they play? First, you need to understand how…
Maybe you’ve heard of amyloid plaques, which build up in the brains of people with Alzheimer’s. But there’s another protein biomarker in the mix:…
TauRx’s experimental drug HMTM is designed to target tau protein, an Alzheimer’s biomarker protein that causes tangles to muck up the works in the…
In Tokyo, a restaurant aims to change stereotypes and raise awareness about dementia by hiring servers with the condition. Known as the Restaurant of…
Is the fountain of youth really filled with Red Bull? Yes, according to some news headlines. “Common energy drink ingredient taurine ‘may slow aging…
The busy life of brain cells is not so different from the supply chain that supports online purchases. A transaction is registered at a…
While some scientists are focused on targeting beta-amyloid plaques to treat Alzheimer’s, others are honing in on another hallmark of the disease — pathological…
Scanning technology is the most definitive way of diagnosing Alzheimer’s disease. One of the most accurate is called a positron emission tomography (PET) scan,…
Model, restaurateur and lifestyle icon Barbara Elaine Smith, known most commonly as B. Smith, died Saturday at age 70 after a seven year fight…
Researchers in Florida have pinpointed a protein that contributes to Alzheimer’s biomarker tau protein accumulation in the brain. They argue it may be a…
Talk with an Alzheimer’s researcher and you’ll likely hear the same lament: Finding a treatment or cure is incredibly challenging because scientists are not…
An Alzheimer’s drug that attacks tau proteins is now being moved into new clinical trials in the U.S. and Europe, according to Singapore-based pharmaceutical…